1. |
AlAli A, Kletke S, Gallie B, et al. Retinoblastoma for pediatric ophthalmologists[J]. Asia Pac J Ophthalmol (Phila), 2018, 7(3): 160-168. DOI: 10.22608/APO.201870.
|
2. |
Aerts I, Lumbroso-Le Rouic L, Gauthier-Villars M, et al. Retinoblastoma update[J]. Arch Pediatr, 2016, 23(1): 112-116. DOI: 10.1016/j.arcped.2015.09.025.
|
3. |
Linn Murphree A. Intraocular retinoblastoma: the case for a new group classification[J]. Ophthalmol Clin North Am, 2005, 18(1): 41-53. DOI: 10.1016/j.ohc.2004.11.003.
|
4. |
Kaliki S, Shields CL, Eagle RC Jr, et al. High-risk intraocular retinoblastoma: comparison between Asian Indians and Americans from two major referral centers[J]. Retina, 2018, 38(10): 2023-2029. DOI: 10.1097/IAE.0000000000001816.
|
5. |
项晓琳, 李彬, 高飞, 等. 以眼球摘除术作为首次治疗的482例视网膜母细胞瘤患者的高危病理因素分析[J]. 中华眼科杂志, 2018, 54(10): 782-786. DOI: 10.3760/cma.j.issn.0412-4081.2018.10.012.Xu XL, Li B, Gao F, et al. Analysis of high-risk histopathologic features of 482 primarily enucleated retinoblastomas[J]. Chin J Ophthalmol, 2018, 54(10): 782-786. DOI: 10.3760/cma.j.issn.0412-4081.2018.10.012.
|
6. |
Xiao W, Ye H, Zeng H, et al. Associations among socioeconomic factors, lag time, and high-risk histopathologic features in eyes primarily enucleated for retinoblastoma[J]. Curr Eye Res, 2019, 44(10): 1144-1149. DOI: 10.1080/02713683.2019.1623898.
|
7. |
Kaliki S, Gupta S, Ramappa G, et al. High-risk retinoblastoma based on age at primary enucleation: a study of 616 eyes[J]. Eye (Lond), 2020, 34(8): 1441-1448. DOI: 10.1038/s41433-019-0698-2.
|
8. |
Fabian ID, Stacey AW, Chowdhury T, et al. High-risk histopathology features in primary and secondary enucleated International Intraocular Retinoblastoma Classification Group D Eyes[J]. Ophthalmology, 2017, 124(6): 851-858. DOI: 10.1016/j.ophtha.2017.01.048.
|
9. |
Brennan RC, Qaddoumi I, Billups CA, et al. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma[J]. Br J Ophthalmol, 2015, 99(10): 1366-1371. DOI: 10.1136/bjophthalmol-2014-306364.
|
10. |
Alkatan HM, Al-Dahmash SA, Almesfer SA, et al. High-risk features in primary versus secondary enucleated globes with advanced retinoblastoma: a retrospective histopathological study[J]. Int Ophthalmol, 2020, 40(11): 2875-2887. DOI: 10.1007/s10792-020-01472-8.
|
11. |
Wilson MW, Qaddoumi I, Billups C, et al. A clinicopathological correlation of 67 eyes primarily enucleated for advanced intraocular retinoblastoma[J]. Br J Ophthalmol, 2011, 95(4): 553-558. DOI: 10.1136/bjo.2009.177444.
|
12. |
Shields CL, Lally SE, Leahey AM, et al. Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy[J]. Curr Opin Ophthalmol, 2014, 25(5): 374-385. DOI: 10.1097/ICU.0000000000000091.
|
13. |
Dikkaya F, Sarıcı AM, Erbek F, et al. Evaluation of high-risk features of primary enucleation of patients with retinoblastoma in a tertiary center of a developing country in the era of intra-arterial chemotherapy[J]. Int Ophthalmol, 2018, 38(1): 151-156. DOI: 10.1007/s10792-016-0436-8.
|